Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • INVESTOR RELATIONS
  • CONTACT
Menu
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • INVESTOR RELATIONS
  • CONTACT

CDX signs exclusive commercialization agreement with Genomic granting a license to develop and commercialize tests for early diagnosis of prostate cancer

Merchavia 29.11.2017 CDXבהסכם רשיון בלעדי עם GENOMIC להענק רישיון לפיתוח ולמסחור בדיקות לאבחון מוקדם של סרטן הערמונית

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
CONTACT